Company intelligence / Profile preview

Colliers

Ownership: Public · CIGI
Employees: ~19000
Development stage: Commercial

Overview

Colliers is a leading global commercial real estate services and investment management firm. The company has dedicated practice groups specializing in life sciences and healthcare real estate solutions but does not develop therapeutics or medical products. Its expertise includes site selection, project management for lab/manufacturing facilities, strategic advisory for health systems and biopharma companies, and supporting the infrastructure needs of R&D organizations[1][2][3][4].

Industry: Consulting

Partnerships

No major pharmaceutical or biotech partnerships as an R&D partner; works with many biopharma clients on their facility needs.

Financials

Market cap: $4.7B
Total revenue: $1.6B
Enterprise value: $7.7B

Beyond the preview

Go deeper on Colliers.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colliers.

Explore the full profile